Assignee
ISARNA THERAPEUTICS GMBH
DE·6 granted patents·2 pending applications·1 citations·filing 2014–2018
Top patents by PatentIndex Score
8 records- 0169US9688988B2Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2014·Granted Jun 27, 2017·1 cites·11 claims
- 0255US9926563B2Modified TGF-beta oligonucleotidesISARNA THERAPEUTICS GMBH·Filed 2014·Granted Mar 27, 2018·0 cites·10 claims
- 0354US9840707B2Modified TGF-beta2 oligonucleotidesISARNA THERAPEUTICS GMBH·Filed 2014·Granted Dec 12, 2017·0 cites·6 claims
- 0454US2019144865A1Modified tgf-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2018·Application pending·0 cites
- 0552US10125368B2Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2017·Granted Nov 13, 2018·0 cites·9 claims
- 0649US10538768B2Modified TGF-beta oligonucleotidesISARNA THERAPEUTICS GMBH·Filed 2018·Granted Jan 21, 2020·0 cites·5 claims
- 0746US2018087055A1Modified tgf-beta2 oligonucleotidesISARNA THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
- 0837US11207341B2TGF-beta oligonucleotide for use in treatment of ophthalmic diseasesISARNA THERAPEUTICS GMBH·Filed 2017·Granted Dec 28, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when ISARNA THERAPEUTICS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →